Nadeau talks food allergy breakthroughs
In a Q&A, immunologist Kari Nadeau discusses advances in food-allergy treatment and research, including a growing body of evidence that patients with several food allergies can be safely treated for all of them at once.
Flu vaccination in a time of COVID-19
It’s time to get a flu shot. In a Q&A, Shanthi Kappagoda, MD, clinical associate professor of infectious diseases, explains why it’s especially important to be vaccinated this year.
Researchers on wildfires’ health impacts
California’s massive wildfires bring a host of health concerns. In a Q&A, Kari Nadeau and Mary Prunicki of the Sean N. Parker Center for Allergy and Asthma Research at Stanford discuss the threats posed by air pollution from the fires.
Race, ethnicity, ancestry in science
Alice Popejoy, a postdoctoral scholar who studies biomedical data sciences, speaks to the role — and pitfalls — of race, ethnicity and ancestry in research.
Scientists contribute to WHO mask guidelines
Scientists say we should wear masks to control the spread of COVID-19. Stanford experts share the evidence that informed the World Health Organization’s recommendations.
AHA chief on research, health equity and more
Robert Harrington, the new president of the American Heart Association, recently discussed his views on technology and diversity in medicine.
Real-world data in the clinic
In an interview, computational biologist Tina Hernandez-Boussard discusses analyzing the value of electronic health records as a source of information in the clinic.
Dennis Wall on new discoveries in autism genetics
Wall discusses how he and his collaborators used whole-genome data from hundreds of families affected by autism to identify 16 new autism risk genes and a rare genetic syndrome that explains some cases of the disorder.
Increasing diversity in genome studies
Data scientist Genevieve Wojcik speaks about the lack of diversity in genomewide association studies, why it’s a problem and how increasing diversity in these studies can elevate the entire population.
Using RNA for rare-disease diagnosis
Geneticist Stephen Montgomery explains why the transcriptome, the collection of RNA molecules in a cell, is a crucial piece of deciphering the source of rare diseases.
Stanford Medicine is closely monitoring the outbreak of novel coronavirus (COVID-19). A dedicated page provides the latest information and developments related to the pandemic.
Leading In Precision Health
Stanford Medicine is leading the biomedical revolution in precision health, defining and developing the next generation of care that is proactive, predictive and precise.